Luigi Vetrugno

Prof. Luigi Vetrugno

Department of Medicine, Anesthesia and Intensive Care Clinic, University of Udine, 33100 Udine, Italy
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2020 in European Journal of Emergency Medicine
Verified
Journal Article
Closed access
DODaniele Orso
Daniele Orso
NFNicola Federici
Nicola Federici
RCRoberto Copetti
Roberto Copetti
Luigi VetrugnoLuigi Vetrugno
Luigi Vetrugno
TBTiziana Bove
Tiziana Bove

8 April 2022 in Critical Care
Verified
Journal Article
Open access
PDF file
MHMark E. Haaksma
Mark E. Haaksma
JSJasper M. Smit
Jasper M. Smit
ABAlain Boussuges
Alain Boussuges
ADAlexandre Demoule
Alexandre Demoule
MDMartin Dres
Martin Dres
PTPieter R. Tuinman
Pieter R. Tuinman
Background: Diaphragm ultrasonography is rapidly evolving in both critical care and research. Nevertheless, methodologically robust guidelines on its methodology and acquiring expertise do not, or only partially, exist. Therefore, we set out to provide consensus-based statements towards a universal measurement protocol for diaphragm ultrasonography and establish key areas for research. Methods: To formulate a robust expert consensus statement, between November 2020 and May 2021, a two-round, anonymous and online survey-based Delphi study among experts in the field was performed. Based on the literature review, the following domains were chosen: “Anatomy and physiology”, “Transducer Settings”, “Ventilator Impact”, “Learning and expertise”, “Daily practice” and “Future directions”. Agreement of ≥ 68% (≥ 10 panelists) was needed to reach consensus on a question. Results: Of 18 panelists invited, 14 agreed to participate in the survey. After two rounds, the survey included 117 questions of which 42 questions were designed to collect arguments and opinions and 75 questions aimed at reaching consensus. Of these, 46 (61%) consensus was reached. In both rounds, the response rate was 100%. Among others, there was agreement on measuring thickness between the pleura and peritoneum, using > 10% decrease in thickness as cut-off for atrophy and using 40 examinations as minimum training to use diaphragm ultrasonography in clinical practice. In addition, key areas for research were established. Conclusion: This expert consensus statement presents the first set of consensus-based statements on diaphragm ultrasonography methodology. They serve to ensure high-quality and homogenous measurements in daily clinical practice and in research. In addition, important gaps in current knowledge and thereby key areas for research are established. Trial registration The study was pre-registered on the Open Science Framework with registration digital object identifier https://doi.org/10.17605/OSF.IO/HM8UG.

1 April 2020 in Echocardiography
Verified
Journal Article
Closed access
PDF file
Luigi VetrugnoLuigi Vetrugno
Luigi Vetrugno
TBTiziana Bove
Tiziana Bove
DODaniele Orso
Daniele Orso
FBFederico Barbariol
Federico Barbariol
FBFlavio Bassi
Flavio Bassi
RKRobert Kong
Robert Kong

20 March 2021 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
GVGiovanni Volpicelli
Giovanni Volpicelli
LGLuna Gargani
Luna Gargani
SPStefano Perlini
Stefano Perlini
SSStefano Spinelli
Stefano Spinelli
GBGreta Barbieri
Greta Barbieri
DFDiego Franchini
Diego Franchini

28 December 2017 in Critical Care
Verified
Journal Article
Open access
PDF file
EBEtrusca Brogi
Etrusca Brogi
LGLuna Gargani
Luna Gargani
EBE. Bignami
E. Bignami
FBF. Barbariol
F. Barbariol
AMannachiara marra
annachiara marra
Luigi VetrugnoLuigi Vetrugno
Luigi Vetrugno
Pleural effusion (PLEFF), mostly caused by volume overload, congestive heart failure, and pleuropulmonary infection, is a common condition in critical care patients. Thoracic ultrasound (TUS) helps clinicians not only to visualize pleural effusion, but also to distinguish between the different types. Furthermore, TUS is essential during thoracentesis and chest tube drainage as it increases safety and decreases life-threatening complications. It is crucial not only during needle or tube drainage insertion, but also to monitor the volume of the drained PLEFF. Moreover, TUS can help diagnose co-existing lung diseases, often with a higher specificity and sensitivity than chest radiography and without the need for X-ray exposure. We review data regarding the diagnosis and management of pleural effusion, paying particular attention to the impact of ultrasound. Technical data concerning thoracentesis and chest tube drainage are also provided.

14 December 2020 in Critical Care
Verified
Journal Article
Open access
PDF file
TIthe H. F.-AECOPD study investigators
the H. F.-AECOPD study investigators
Andrea CortegianiAndrea Cortegiani
Andrea Cortegiani
FLFederico Longhini
Federico Longhini
FMFabiana Madotto
Fabiana Madotto
PGPaolo Groff
Paolo Groff
Cesare GregorettiCesare Gregoretti
Cesare Gregoretti
Background: The efficacy and safety of high flow nasal therapy (HFNT) in patients with acute hypercapnic exacerbation of chronic obstructive pulmonary disease (AECOPD) are unclear. Our aim was to evaluate the short-term effect of HFNT versus NIV in patients with mild-to-moderate AECOPD, with the hypothesis that HFNT is non-inferior to NIV on CO2 clearance after 2 h of treatment. Methods: We performed a multicenter, non-inferiority randomized trial comparing HFNT and noninvasive ventilation (NIV) in nine centers in Italy. Patients were eligible if presented with mild-to-moderate AECOPD (arterial pH 7.25–7.35, PaCO2 ≥ 55 mmHg before ventilator support). Primary endpoint was the mean difference of PaCO2 from baseline to 2 h (non-inferiority margin 10 mmHg) in the per-protocol analysis. Main secondary endpoints were non-inferiority of HFNT to NIV in reducing PaCO2 at 6 h in the per-protocol and intention-to-treat analysis and rate of treatment changes. Results: Seventy-nine patients were analyzed (80 patients randomized). Mean differences for PaCO2 reduction from baseline to 2 h were − 6.8 mmHg (± 8.7) in the HFNT and − 9.5 mmHg (± 8.5) in the NIV group (p = 0.404). By 6 h, 32% of patients (13 out of 40) in the HFNT group switched to NIV and one to invasive ventilation. HFNT was statistically non-inferior to NIV since the 95% confidence interval (CI) upper boundary of absolute difference in mean PaCO2 reduction did not reach the non-inferiority margin of 10 mmHg (absolute difference 2.7 mmHg; 1-sided 95% CI 6.1; p = 0.0003). Both treatments had a significant effect on PaCO2 reductions over time, and trends were similar between groups. Similar results were found in both per-protocol at 6 h and intention-to-treat analysis. Conclusions: HFNT was statistically non-inferior to NIV as initial ventilatory support in decreasing PaCO2 after 2 h of treatment in patients with mild-to-moderate AECOPD, considering a non-inferiority margin of 10 mmHg. However, 32% of patients receiving HFNT required NIV by 6 h. Further trials with superiority design should evaluate efficacy toward stronger patient-related outcomes and safety of HFNT in AECOPD. Trial registration: The study was prospectively registered on December 12, 2017, in ClinicalTrials.gov (NCT03370666).